Compare HAE & DOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HAE | DOX |
|---|---|---|
| Founded | 1971 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.6B |
| IPO Year | 1996 | 1998 |
| Metric | HAE | DOX |
|---|---|---|
| Price | $102.92 | $62.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $84.13 | ★ $92.33 |
| AVG Volume (30 Days) | 663.1K | ★ 1.0M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.56% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $910,373,000.00 | N/A |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | $5.23 | $3.76 |
| P/E Ratio | $142.94 | ★ $13.65 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $47.32 | $49.74 |
| 52 Week High | $109.57 | $85.66 |
| Indicator | HAE | DOX |
|---|---|---|
| Relative Strength Index (RSI) | 62.29 | 70.62 |
| Support Level | $79.52 | $63.03 |
| Resistance Level | $109.57 | $64.12 |
| Average True Range (ATR) | 2.59 | 1.37 |
| MACD | -0.93 | 0.10 |
| Stochastic Oscillator | 62.50 | 90.09 |
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
Amdocs Ltd is a provider of software and services to communications, entertainment, and media service providers. The Company operates in a single segment and designs, develops, markets, supports, implements, and operates open and modular cloud offerings. Its portfolio includes solutions across digital business systems and legacy business and operational support systems, supporting multiple lines of business such as wireless, broadband, cable, fiber, satellite, and digital services. The Company leverages artificial intelligence to support digital transformation, cloud adoption, and intelligent network automation. Geographically, it derives a majority of its revenue from North America and also operates in Europe and the rest of the world.